Back
ESC Professional Premium Access

VEGF beta is a candidate biomarker for cardiovascular risk stratification

Session: Biomarkers and more
Topic: Biomarkers
Speaker: Doctor C. Schulte (Hamburg, DE)
Event: ESC Congress 2022

Congress Presentation

About the speaker

Doctor Christian Schulte

University Heart and Vascular Centre Hamburg (UHZ), Hamburg (Germany)
1 presentation
0 follower

8 more presentations in this session

Patients with known coronary artery disease who are ruled out for acute myocardial infarction using a high sensitivity troponin T 0/1-hour algorithm have increased 30-day major adverse cardiac events

Speaker: Professor R. Nowak (Detroit, US)

Access
Abstract
Slides
Thumbnail

Differences in circulating cardiac troponin I and T in acute and chronic cardiac disease

Speaker: Doctor T. Zimmermann (Basel, CH)

Access
Abstract
Slides
Thumbnail

Growth differentiation factor 15 at 3 months after an acute chest pain admission is associated with increased risk of death and cardiovascular events

Speaker: Doctor G. Myrmel (Bergen, NO)

Access
Abstract
Slides
Thumbnail

Direct comparison of very early AMI rule-out algorithms

Speaker: Doctor C. Pedersen (Aarhus, DK)

Access
Abstract
Slides
Thumbnail

Serial high-sensitivity troponin T concentrations and long-term outcomes in patients with suspected acute coronary syndrome

Speaker: Doctor M. Pareek (Copenhagen, DK) Doctor A. Kristensen (Frederiksberg, DK)

Access
Abstract
Slides
Thumbnail

Access the full session

Biomarkers and more

Speakers: Doctor C. Schulte, Professor R. Nowak, Doctor T. Zimmermann, Doctor G. Myrmel, Doctor C. Pedersen...
Access
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb